GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » EV-to-EBITDA

Moolec Science (Moolec Science) EV-to-EBITDA : -8.21 (As of May. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moolec Science EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Moolec Science's enterprise value is $53.83 Mil. Moolec Science's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.56 Mil. Therefore, Moolec Science's EV-to-EBITDA for today is -8.21.

The historical rank and industry rank for Moolec Science's EV-to-EBITDA or its related term are showing as below:

MLEC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.12   Med: -2.44   Max: -1.67
Current: -8.21

During the past 3 years, the highest EV-to-EBITDA of Moolec Science was -1.67. The lowest was -15.12. And the median was -2.44.

MLEC's EV-to-EBITDA is ranked worse than
100% of 463 companies
in the Biotechnology industry
Industry Median: 9.32 vs MLEC: -8.21

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), Moolec Science's stock price is $1.26. Moolec Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.130. Therefore, Moolec Science's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Moolec Science EV-to-EBITDA Historical Data

The historical data trend for Moolec Science's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science EV-to-EBITDA Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23
EV-to-EBITDA
- - -2.67

Moolec Science Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only - -2.87 -2.67 -2.03 -15.08

Competitive Comparison of Moolec Science's EV-to-EBITDA

For the Biotechnology subindustry, Moolec Science's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moolec Science's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Moolec Science's EV-to-EBITDA falls into.



Moolec Science EV-to-EBITDA Calculation

Moolec Science's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=53.832/-6.557
=-8.21

Moolec Science's current Enterprise Value is $53.83 Mil.
Moolec Science's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moolec Science  (NAS:MLEC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Moolec Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.26/-0.130
=At Loss

Moolec Science's share price for today is $1.26.
Moolec Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.130.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Moolec Science EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Moolec Science's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Moolec Science (Moolec Science) Business Description

Traded in Other Exchanges
N/A
Address
17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.